查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1570844

抗凝血酵素III 测试市场：按产品类型、技术、应用和最终用户划分 - 2025-2030 年全球预测

Anti-Thrombin III Testing Market by Product Type (Cardiac Test Kits, ELISA Test Kits, FIA Test Kits), Technology (Chromogenic Assay, Immunoassay), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年抗凝血酵素III检测市值为9,143万美元，预计2024年将达9,984万美元，复合年增长率为9.39%，预计到2030年将达到17,137万美元。

抗凝血酵素III 检测在医学领域至关重要，因为它在血栓性疾病的诊断和治疗以及确保抗凝血治疗的有效性方面发挥着重要作用。对此测试的需求是由于其在检测导致血栓症形成风险增加的先天性或后天性抗凝血酵素III 缺陷中的应用。其应用涵盖医院实验室、诊断中心和研究机构等医疗保健环境，拥有主要最终用户。市场成长受到血栓栓塞性疾病发病率上升、诊断技术进步以及更容易患凝血疾病的老年人数量增加的影响。人们对凝血障碍的认识不断提高，需求也进一步增加。最近，技术进步带来了潜在的机会，这些进步促进了照护现场诊断工具和人工智慧的集成，以提高准确性和效率。公司可以透过投资研究合作伙伴关係并利用最尖端科技增强产品系列来利用这些机会。然而，市场成长面临严格的监管要求、高昂的测试成本以及需要熟练的专业人员执行测试和准确解释结果等挑战。这些限制可能会阻碍采用，特别是在低收入地区。创新和研究应着重于增强非侵入性检测方法、降低成本并利用数位技术确保更容易获得和简化诊断。强调个人化医疗方法并开发强大的预测模型将为业务成长开闢新的途径。这个市场本​​质上是协作性的，与医院、诊断服务供应商和学术研究机构的伙伴关係可以推动创新。总体而言，市场格局是动态的，儘管存在挑战，但技术创新和策略市场参与的整合可以提供重大的成长机会。

主要市场统计
基准年[2023] 9143万美元
预测年份 [2024] 9984万美元
预测年份 [2030] 17137万美元
复合年增长率（%） 9.39%

市场动态：揭示快速发展的抗凝血酵素III 测试市场的关键市场洞察

抗凝血酵素III 检测市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，以及消费行为及其对製造业的影响，您还可以更清楚地了解其对成本和采购趋势的影响。

波特五力：驾驭抗凝血酵素III 测试市场的策略工具

波特五力框架是了解抗凝血酵素III 测试市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解抗凝血酵素III 检测市场的外部影响

外部宏观环境因素在塑造抗凝血酵素III 测试市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解抗凝血酵素III 检测市场的竞争格局

抗凝血酵素III 测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵抗凝血酵素III 测试市场供应商的绩效评估

FPNV 定位矩阵是评估抗凝血酵素III 测试市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划抗凝血酵素III 测试市场的成功之路

抗凝血酵素III 测试市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告提供了涵盖关键焦点细分市场的全面市场分析。

1. 市场渗透率：对当前市场环境的详细回顾。

2. 市场开拓：辨识新兴市场的成长机会，评估现有产业的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检视市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要抗凝血酶 III 监测以改善手术全期护理的外科手术数量增加
      • 越来越多的老年人需要定期预防血栓症
      • 扩大新兴国家的医疗基础设施
    • 抑制因素
      • 擅长抗凝血酵素III 检测的专家和专业实验室数量有限
    • 机会
      • 扩大心血管医疗机构的抗凝血酵素III 检测服务
      • 与生技公司合作创新新的抗凝血酵素III 测试方法
    • 任务
      • 监管合规性和严格的指导方针
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章抗凝血酵素III 检测市场：依产品类型

  • 介绍
  • 心臟检测套组
  • ELISA检测套组
  • 国际汽联测试套件

第七章抗凝血酵素III 检测市场：依技术分类

  • 介绍
  • 比色测定
  • 免疫检测

第八章抗凝血酵素III 检测市场：依应用分类

  • 介绍
  • 诊断实验室
    • 医院实验室
    • 独立诊断实验室
  • 就地检验
  • 研究/学术机构
    • 临床研究单位
    • 大学/短期大学

第 9 章抗凝血酵素III 检验市场：依最终使用者分类

  • 介绍
  • 门诊手术中心
  • 诊断实验室
  • 医院
  • 专科诊所

第十章美洲抗凝血酵素III检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区抗凝血酵素III检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲抗凝血酵素III检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C0463

The Anti-Thrombin III Testing Market was valued at USD 91.43 million in 2023, expected to reach USD 99.84 million in 2024, and is projected to grow at a CAGR of 9.39%, to USD 171.37 million by 2030.

Anti-Thrombin III Testing is essential in the medical field as it plays a crucial role in diagnosing and managing thrombotic disorders and ensuring the efficacy of anticoagulant therapies. The necessity of this testing is driven by its application in detecting congenital or acquired deficiencies in Anti-Thrombin III, which can lead to an increased risk of thrombosis. Its applications span across healthcare settings such as hospital laboratories, diagnostic centers, and research institutions, which serve as the primary end-users. Market growth is influenced by rising incidences of thromboembolic disorders, advancements in diagnostic technologies, and an increasing elderly population prone to blood clotting disorders. The growing awareness about coagulation disorders further amplifies the demand. Recently, potential opportunities have arisen from technological advancements that facilitate point-of-care diagnostic tools and the integration of Artificial Intelligence for improved accuracy and efficiency. Companies can capitalize on these opportunities by investing in research partnerships and enhancing their product portfolios with cutting-edge technologies. However, market growth faces challenges such as stringent regulatory requirements, high testing costs, and the need for skilled professionals to conduct and interpret results accurately. These limitations could hinder widespread adoption, particularly in low-income regions. Innovation and research should focus on enhancing non-invasive testing methods, reducing costs, and leveraging digital technologies to ensure easier access and streamlined diagnostics. Emphasizing personalized medicine approaches and developing robust predictive models can open new avenues for business growth. The market is inherently collaborative, where partnerships with hospitals, diagnostic service providers, and academic research bodies could propel innovation. Overall, the Anti-Thrombin III Testing market presents a dynamic landscape where the amalgamation of technological innovation and strategic market engagements can offer substantial growth opportunities despite existing challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 91.43 million
Estimated Year [2024] USD 99.84 million
Forecast Year [2030] USD 171.37 million
CAGR (%) 9.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Thrombin III Testing Market

The Anti-Thrombin III Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising number of surgical procedures requiring anti-thrombin III monitoring for better perioperative care
    • Increase in geriatric population prone to thrombotic disorders necessitating regular anti-thrombin III testing
    • Expansion of healthcare infrastructure in emerging economies
  • Market Restraints
    • Limited availability of skilled professionals and specialized laboratories for anti-thrombin III testing
  • Market Opportunities
    • Expansion of anti-thrombin III testing services in specialized cardiovascular care facilities
    • Collaborations with biotechnology firms to innovate new anti-thrombin III testing methodologies
  • Market Challenges
    • Regulatory compliance and stringent guidelines

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Thrombin III Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Thrombin III Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Thrombin III Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Thrombin III Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Thrombin III Testing Market

A detailed market share analysis in the Anti-Thrombin III Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Thrombin III Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Thrombin III Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anti-Thrombin III Testing Market

A strategic analysis of the Anti-Thrombin III Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anti-Thrombin III Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, bioMerieux, Chrono-log Corporation, Danaher Corporation, DiaSorin, Grifols, Immucor, Instrumentation Laboratory, Merck KGaA, PerkinElmer, Quidel Corporation, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, and Werfen.

Market Segmentation & Coverage

This research report categorizes the Anti-Thrombin III Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cardiac Test Kits, ELISA Test Kits, and FIA Test Kits.
  • Based on Technology, market is studied across Chromogenic Assay and Immunoassay.
  • Based on Application, market is studied across Diagnostic Laboratories, Point of Care Testing, and Research and Academic Institutes. The Diagnostic Laboratories is further studied across Hospital Laboratories and Independent Diagnostics Laboratories. The Research and Academic Institutes is further studied across Clinical Research Units and Universities & Colleges.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of surgical procedures requiring anti-thrombin III monitoring for better perioperative care
      • 5.1.1.2. Increase in geriatric population prone to thrombotic disorders necessitating regular anti-thrombin III testing
      • 5.1.1.3. Expansion of healthcare infrastructure in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled professionals and specialized laboratories for anti-thrombin III testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of anti-thrombin III testing services in specialized cardiovascular care facilities
      • 5.1.3.2. Collaborations with biotechnology firms to innovate new anti-thrombin III testing methodologies
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory compliance and stringent guidelines
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anti-Thrombin III Testing Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cardiac Test Kits
  • 6.3. ELISA Test Kits
  • 6.4. FIA Test Kits

7. Anti-Thrombin III Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Chromogenic Assay
  • 7.3. Immunoassay

8. Anti-Thrombin III Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
    • 8.2.1. Hospital Laboratories
    • 8.2.2. Independent Diagnostics Laboratories
  • 8.3. Point of Care Testing
  • 8.4. Research and Academic Institutes
    • 8.4.1. Clinical Research Units
    • 8.4.2. Universities & Colleges

9. Anti-Thrombin III Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Laboratories
  • 9.4. Hospitals
  • 9.5. Specialty Clinics

10. Americas Anti-Thrombin III Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Anti-Thrombin III Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Anti-Thrombin III Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories
  • 5. bioMerieux
  • 6. Chrono-log Corporation
  • 7. Danaher Corporation
  • 8. DiaSorin
  • 9. Grifols
  • 10. Immucor
  • 11. Instrumentation Laboratory
  • 12. Merck KGaA
  • 13. PerkinElmer
  • 14. Quidel Corporation
  • 15. Roche Diagnostics
  • 16. Sekisui Diagnostics
  • 17. Siemens Healthineers
  • 18. Sysmex Corporation
  • 19. Thermo Fisher Scientific
  • 20. Werfen

LIST OF FIGURES

  • FIGURE 1. ANTI-THROMBIN III TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANTI-THROMBIN III TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANTI-THROMBIN III TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANTI-THROMBIN III TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTI-THROMBIN III TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTI-THROMBIN III TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CARDIAC TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY ELISA TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY FIA TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY INDEPENDENT DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY CLINICAL RESEARCH UNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY UNIVERSITIES & COLLEGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTI-THROMBIN III TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES ANTI-THROMBIN III TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY RESEARCH AND ACADEMIC INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ANTI-THROMBIN III TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. ANTI-THROMBIN III TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. ANTI-THROMBIN III TESTING MARKET, FPNV POSITIONING MATRIX, 2023